|
Market Cap | 1.08B | EPS (ttm) | -0.00 |
P/E | - | EPS this Y | 600.61% |
Forward P/E | 89.21 | EPS next Y | 294.96% |
PEG | - | EPS past 5Y | 19.99% |
P/S | 2.59 | EPS next 5Y | 16.03% |
P/B | 2.47 | EPS Q/Q | -265.54% |
Dividend | - | Sales Q/Q | 18.99% |
Insider Own | 0.06% | Inst Own | 34.19% |
Insider Trans | 0.00% | Inst Trans | -10.59% |
Short Float | 5.44% | Earnings | May 21/b |
Analyst Recom | 1.50 | Target Price | 8.91 |
Avg Volume | 4.16M | 52W Range | 2.22 - 8.44 |
|
|
|
Gaotu Techedu, Inc. is a technology-driven education company. The company was founded by Xiang Dong Chen in June 2014 and is headquartered in Beijing, China. |
|
|
|
Market Cap | 127.28B | EPS (ttm) | 13.17 |
P/E | 16.89 | EPS this Y | -6.75% |
Forward P/E | 16.55 | EPS next Y | 10.02% |
PEG | 3.25 | EPS past 5Y | 35.96% |
P/S | 1.47 | EPS next 5Y | 5.20% |
P/B | - | EPS Q/Q | 12.16% |
Dividend | 2.03% | Sales Q/Q | -17.12% |
Insider Own | 0.13% | Inst Own | 75.76% |
Insider Trans | -4.31% | Inst Trans | -3.69% |
Short Float | 1.22% | Earnings | May 21/b |
Analyst Recom | 2.37 | Target Price | 253.30 |
Avg Volume | 2.32M | 52W Range | 181.85 - 262.49 |
|
|
|
Lowe's Companies, Inc. engages in the retail sale of home improvement products. The firm offers products for maintenance, repair, remodeling, home decorating, and property maintenance. It also provides home improvement products in the following categories: appliances, seasonal & outdoor living, lumber, lawn & garden, kitchens & bath, hardware, building materials, millwork, paint, rough plumbing, tools, electrical, flooring, and decor. The company was founded in 1946 and is headquartered in Mooresville, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Boltz William P | EVP, Merchandising | Apr 01 '24 | Option Exercise | 0.00 | 14,798 | 0 | 38,927 | Apr 03 04:41 PM | Griggs Dan Clayton Jr | SVP, Tax & CAO | Apr 01 '24 | Option Exercise | 0.00 | 2,487 | 0 | 9,048 | Apr 03 04:40 PM | Godbole Seemantini | EVP, Chief Information Officer | Apr 01 '24 | Option Exercise | 0.00 | 11,774 | 0 | 33,020 | Apr 03 04:42 PM | Ellison Marvin R | Chairman, President & CEO | Apr 01 '24 | Option Exercise | 0.00 | 49,601 | 0 | 274,448 | Apr 03 04:44 PM | Vance Quonta D | EVP, Pro & Home Services | Apr 01 '24 | Option Exercise | 0.00 | 2,546 | 0 | 15,819 | Apr 03 04:46 PM |
|
|
|
|
Market Cap | 70.46M | EPS (ttm) | -1.59 |
P/E | - | EPS this Y | 3.61% |
Forward P/E | - | EPS next Y | -44.71% |
PEG | - | EPS past 5Y | 86.55% |
P/S | 10.41 | EPS next 5Y | - |
P/B | 1.38 | EPS Q/Q | 57.45% |
Dividend | - | Sales Q/Q | -86.63% |
Insider Own | 46.29% | Inst Own | 14.31% |
Insider Trans | 0.00% | Inst Trans | -2.71% |
Short Float | 0.86% | Earnings | May 21/b |
Analyst Recom | 1.00 | Target Price | 6.00 |
Avg Volume | 1.08M | 52W Range | 1.13 - 6.47 |
|
|
|
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands. |
|
| |
|
Market Cap | 5.24B | EPS (ttm) | 0.37 |
P/E | 50.84 | EPS this Y | -24.21% |
Forward P/E | 7.33 | EPS next Y | -2.06% |
PEG | - | EPS past 5Y | -36.16% |
P/S | 0.22 | EPS next 5Y | -3.22% |
P/B | 1.26 | EPS Q/Q | -114.15% |
Dividend | 3.58% | Sales Q/Q | -1.77% |
Insider Own | 0.74% | Inst Own | 82.47% |
Insider Trans | -13.63% | Inst Trans | -4.77% |
Short Float | 5.92% | Earnings | May 21/b |
Analyst Recom | 2.80 | Target Price | 20.36 |
Avg Volume | 6.96M | 52W Range | 10.54 - 22.10 |
|
|
|
Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gennette Jeffrey | Director | Apr 01 '24 | Sale | 19.66 | 30,090 | 591,422 | 1,073,699 | Apr 02 01:03 PM | Spring Antony | CEO & Chair-Elect | Apr 01 '24 | Sale | 19.63 | 14,859 | 291,743 | 248,897 | Apr 02 01:10 PM | Mitchell Adrian V | EVP, COO & CFO | Apr 01 '24 | Sale | 19.63 | 13,279 | 260,716 | 120,457 | Apr 02 01:09 PM | Kirgan Danielle L. | EVP, Chief Transformation & HR | Apr 01 '24 | Sale | 19.66 | 6,680 | 131,297 | 324,635 | Apr 02 01:07 PM | Griscom Paul | SVP and Controller | Apr 01 '24 | Sale | 19.64 | 522 | 10,251 | 25,553 | Apr 02 01:05 PM |
|
|
|
|
Market Cap | 86.41M | EPS (ttm) | -1.37 |
P/E | - | EPS this Y | 110.58% |
Forward P/E | - | EPS next Y | -147.15% |
PEG | - | EPS past 5Y | 21.99% |
P/S | 0.17 | EPS next 5Y | 9.19% |
P/B | 0.22 | EPS Q/Q | 57.21% |
Dividend | - | Sales Q/Q | -26.74% |
Insider Own | 1.10% | Inst Own | 4.33% |
Insider Trans | 0.00% | Inst Trans | -5.10% |
Short Float | 0.12% | Earnings | May 21/b |
Analyst Recom | 3.00 | Target Price | 4.23 |
Avg Volume | 19.77K | 52W Range | 1.75 - 6.00 |
|
|
|
OneConnect Financial Technology Co. Ltd. engages in providing cloud-native technology solutions to financial institutions in China. Its solutions provide technology applications and technology-enabled business services to financial institutions. It operates through the Technology Solution and Virtual Bank Business segments. The Technology Solution segment includes implementation revenue and transaction-based and support services revenue. The Virtual Bank Business segment represents interest income from the lending business of its virtual bank and fees and commission from the firm's banking operations. The company was founded in December 2015 and is headquartered in Shenzhen, China. |
|
| |
|
Market Cap | 3.81M | EPS (ttm) | -1.52 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.69 | EPS next 5Y | - |
P/B | 0.75 | EPS Q/Q | 46.69% |
Dividend | - | Sales Q/Q | 17.40% |
Insider Own | 31.84% | Inst Own | 1.52% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.84% | Earnings | May 21/b |
Analyst Recom | 1.00 | Target Price | 3.00 |
Avg Volume | 214.06K | 52W Range | 0.39 - 2.40 |
|
|
|
Onfolio Holdings, Inc. engages in the provision of technology services. It operates through the following business models: D2C eCommerce, B2B SEO, and Marketing Services as well as B2B digital products. The company was founded by Dominic Wells on July 20, 2020 and is headquartered in Wilmington. DE. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Byalik Yury | Head of Strategy & Acquisition | May 26 '23 | Buy | 1.17 | 635 | 743 | 118,804 | May 30 11:50 AM | Byalik Yury | Head of Strategy & Acquisition | May 25 '23 | Buy | 1.17 | 1,269 | 1,485 | 118,169 | May 30 11:50 AM |
|
|
|
|
Market Cap | 18.05M | EPS (ttm) | -1.52 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -5.89% |
P/S | 34.06 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 66.33% |
Dividend | - | Sales Q/Q | -0.70% |
Insider Own | 15.62% | Inst Own | 6.44% |
Insider Trans | 7.51% | Inst Trans | 0.08% |
Short Float | 0.99% | Earnings | May 21/b |
Analyst Recom | 1.00 | Target Price | 6.00 |
Avg Volume | 180.67K | 52W Range | 0.25 - 1.50 |
|
|
|
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Miller Victor | Chief Financial Officer | Apr 01 '24 | Option Exercise | 0.50 | 25,000 | 12,500 | 25,000 | Apr 02 12:31 PM | Safier Jacob | 10% Owner | Feb 01 '24 | Buy | 0.33 | 10,100 | 3,332 | 3,110,100 | Feb 14 09:32 PM | Safier Jacob | 10% Owner | Jan 31 '24 | Buy | 0.35 | 5,000 | 1,726 | 3,100,000 | Feb 14 09:31 PM | Safier Jacob | 10% Owner | Jan 30 '24 | Buy | 0.33 | 25,000 | 8,245 | 3,095,000 | Feb 14 09:31 PM | Safier Jacob | 10% Owner | Jan 26 '24 | Buy | 0.32 | 25,000 | 8,000 | 3,070,000 | Feb 14 09:31 PM |
|
|
| |
|
Market Cap | 704.99M | EPS (ttm) | -0.07 |
P/E | - | EPS this Y | 21.00% |
Forward P/E | - | EPS next Y | 44.22% |
PEG | - | EPS past 5Y | -289.85% |
P/S | 6.31 | EPS next 5Y | - |
P/B | 1.54 | EPS Q/Q | 122.32% |
Dividend | - | Sales Q/Q | 6.35% |
Insider Own | 83.44% | Inst Own | 5.39% |
Insider Trans | 0.00% | Inst Trans | -0.38% |
Short Float | 0.18% | Earnings | May 21/b |
Analyst Recom | 1.50 | Target Price | 5.83 |
Avg Volume | 34.79K | 52W Range | 3.15 - 4.65 |
|
|
|
PropertyGuru Group Ltd. is an online property technology company, which engages in the provision of online real estate services. It operates through the following segments: Singapore, Vietnam, Malaysia, Other Asia, and Fintech and Data Services. The company was founded by Stephen Nicholas Melhuish and Jani Rautiainen in 2007 and is headquartered in Singapore. |
|
|
|
Market Cap | 19.34M | EPS (ttm) | -0.65 |
P/E | - | EPS this Y | 50.98% |
Forward P/E | - | EPS next Y | 12.00% |
PEG | - | EPS past 5Y | -28.31% |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | -40.51% |
Dividend | - | Sales Q/Q | - |
Insider Own | 54.07% | Inst Own | 0.24% |
Insider Trans | -0.12% | Inst Trans | -0.16% |
Short Float | 0.66% | Earnings | May 21/b |
Analyst Recom | 1.00 | Target Price | 3.00 |
Avg Volume | 2.64M | 52W Range | 0.19 - 0.86 |
|
|
|
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
OrbiMed Israel BioFund GP Limi | 10% Owner | May 15 '24 | Sale | 0.38 | 24,344 | 9,280 | 13,773,653 | May 20 04:39 PM | Oron Assaf | Chief Business Officer | Nov 29 '23 | Sale | 0.37 | 10,914 | 4,072 | 0 | Dec 01 04:46 PM | Oron Assaf | Chief Business Officer | May 22 '23 | Buy | 0.27 | 3,192 | 872 | 10,914 | May 24 06:03 AM |
|
|
|
|
Market Cap | 14.70M | EPS (ttm) | -0.91 |
P/E | - | EPS this Y | 29.63% |
Forward P/E | - | EPS next Y | 16.32% |
PEG | - | EPS past 5Y | 26.09% |
P/S | - | EPS next 5Y | - |
P/B | 0.40 | EPS Q/Q | 39.70% |
Dividend | - | Sales Q/Q | - |
Insider Own | 0.75% | Inst Own | 9.99% |
Insider Trans | 0.00% | Inst Trans | -12.19% |
Short Float | 1.14% | Earnings | May 21/b |
Analyst Recom | 1.00 | Target Price | 9.67 |
Avg Volume | 151.69K | 52W Range | 0.30 - 1.98 |
|
|
|
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel. |
|
|